The LEAD program was developed to support early-career investigators from racial/ethnic minority groups that are traditionally underrepresented in the substance use disorder research field. This program is integrated within the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) and serves as a platform for training early career research scientists. Based at the University of California, San Francisco (UCSF), this 3-year training program utilizes a team mentoring approach. Visiting scholars spend three summers in a funded 4-week intensive program at UCSF and during the academic year, will work with their primary mentor to collaborate on substance use disorder treatment research conducted in the CTN, develop a professional research network, and conduct a pilot study that will serve as a preliminary study for subsequent NIH funding. The 2022 summer program begins on June 20th and ends July 15th. Please access the following flyer for eligibility criteria and more information or visit this link to learn more about the program.


For consideration, apply before the April 15, 2022 application deadline.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.